KALA BIO Statistics
Total Valuation
KALA BIO has a market cap or net worth of $26.52 million. The enterprise value is $17.03 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KALA BIO has 6.45 million shares outstanding. The number of shares has increased by 78.73% in one year.
Current Share Class | 6.45M |
Shares Outstanding | 6.45M |
Shares Change (YoY) | +78.73% |
Shares Change (QoQ) | +35.17% |
Owned by Insiders (%) | 3.86% |
Owned by Institutions (%) | 30.13% |
Float | 3.80M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.71 |
P/TBV Ratio | 4.71 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.99, with a Debt / Equity ratio of 5.67.
Current Ratio | 1.99 |
Quick Ratio | 1.84 |
Debt / Equity | 5.67 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.25 |
Financial Efficiency
Return on equity (ROE) is -576.46% and return on invested capital (ROIC) is -60.45%.
Return on Equity (ROE) | -576.46% |
Return on Assets (ROA) | -48.51% |
Return on Invested Capital (ROIC) | -60.45% |
Return on Capital Employed (ROCE) | -155.51% |
Revenue Per Employee | n/a |
Profits Per Employee | -$938,184 |
Employee Count | 38 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.82% in the last 52 weeks. The beta is -1.98, so KALA BIO's price volatility has been lower than the market average.
Beta (5Y) | -1.98 |
52-Week Price Change | -39.82% |
50-Day Moving Average | 3.88 |
200-Day Moving Average | 6.01 |
Relative Strength Index (RSI) | 55.51 |
Average Volume (20 Days) | 42,052 |
Short Selling Information
The latest short interest is 286,860, so 4.45% of the outstanding shares have been sold short.
Short Interest | 286,860 |
Short Previous Month | 404,588 |
Short % of Shares Out | 4.45% |
Short % of Float | 7.55% |
Short Ratio (days to cover) | 3.24 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -39.31M |
Pretax Income | -38.72M |
Net Income | -35.65M |
EBITDA | -39.05M |
EBIT | -39.31M |
Earnings Per Share (EPS) | -$7.62 |
Full Income Statement Balance Sheet
The company has $42.22 million in cash and $32.35 million in debt, giving a net cash position of $9.87 million or $1.53 per share.
Cash & Cash Equivalents | 42.22M |
Total Debt | 32.35M |
Net Cash | 9.87M |
Net Cash Per Share | $1.53 |
Equity (Book Value) | 5.71M |
Book Value Per Share | 0.88 |
Working Capital | 22.74M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$27.36 million and capital expenditures -$195,000, giving a free cash flow of -$27.56 million.
Operating Cash Flow | -27.36M |
Capital Expenditures | -195,000 |
Free Cash Flow | -27.56M |
FCF Per Share | -$4.27 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KALA BIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -78.73% |
Shareholder Yield | -78.73% |
Earnings Yield | -132.50% |
FCF Yield | -102.42% |
Analyst Forecast
The average price target for KALA BIO is $14.00, which is 240.63% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $14.00 |
Price Target Difference | 240.63% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.
Last Split Date | Oct 21, 2022 |
Split Type | Reverse |
Split Ratio | 0.02:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |